Globus Medical (GMED) Profit After Tax (2011 - 2026)

Globus Medical (GMED) has reported Profit After Tax for 16 consecutive years, with $151.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Profit After Tax fell 29.59% year-over-year to $151.6 million; the trailing twelve-month figure through Jun 2026 stood at $539.6 million (up 42.47% YoY), and the FY2025 full-year result was $560.1 million, up 426.81% from the prior year.
• Profit After Tax rose to $151.6 million in Q2 2026 per GMED's latest filing, from $123.4 million in the prior quarter.
• Across five years, Profit After Tax topped out at $215.3 million in Q2 2025 and bottomed at -$8.0 million in Q1 2024.
• Historically, Profit After Tax has averaged $69.9 million across 5 years, with a median of $55.5 million in 2023.
• The widest YoY moves for Profit After Tax: up 4168.17% in 2024, down 114.67% in 2024.
• Over 5 years, Profit After Tax stood at $57.7 million in 2022, then tumbled by 59.11% to $23.6 million in 2023, then increased by 12.85% to $26.6 million in 2024, then jumped by 445.02% to $145.0 million in 2025, then advanced by 4.52% to $151.6 million in 2026.
• According to Business Quant data, Profit After Tax over the past three periods registered $151.6 million, $123.4 million, and $145.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.